Invention Grant
- Patent Title: Human PD-L2 antibodies and methods of use therefor
-
Application No.: US17040269Application Date: 2019-03-15
-
Publication No.: US11976128B2Publication Date: 2024-05-07
- Inventor: Michael A. Curran , Ashvin R. Jaiswal , Dongxing Zha , Kui Voo , Carlo Toniatti , Bianka Prinz , Nadthakarn Boland
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2019/022444 2019.03.15
- International Announcement: WO2019/182888A 2019.09.26
- Date entered country: 2020-09-22
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00
Abstract:
The present disclosure is directed to antibodies binding to PD-L2 and methods of using such antibodies to treat cancers, such as those that express or overexpress PD-L2.
Public/Granted literature
- US20230174661A1 HUMAN PD-L2 ANTIBODIES AND METHODS OF USE THEREFOR Public/Granted day:2023-06-08
Information query
